Search
News & Events
Funding boost for digital health programThe Kids Research Institute Australia is pleased to share in $490,000 in State Government funding designed to provide vital support to WA’s innovation sector in the wake of COVID-19.
News & Events
Sophisticated new modelling suggests keeping mask mandate could prevent 147,000 COVID-19 casesWA’s current Omicron COVID-19 outbreak could jump by 147,000 cases if mask mandates are abandoned before the Easter long weekend, according to sophisticated new modelling.
News & Events
Australia one step closer to COVID-19 shot for under 5sAustralia’s TGA has granted a provisional determination to Pfizer, allowing the pharmaceutical company to apply for approval to extend its COVID-19 vaccine to children aged 6 mths - 4 yrs.
Research
Comorbidities and confusion: addressing COVID-19 vaccine access and information challengesEarly in the coronavirus disease 2019 (COVID-19) pandemic, evidence emerged that individuals with chronic and immunocompromising conditions faced increased risk of severe infection, including death. The Australian Government and public health authorities prioritised these citizens' access to vaccines, including them in phase 1b of the rollout from 22 March 2021.
News & Events
COVID-19 risks explained for babies, children and pregnant womenMany parents may be feeling anxious and confused about what COVID-19 means for pregnant women, babies and children.
The Kids Research Institute Australia position on schools and COVID-19 in Western Australia
A letter to the WA public from Jonathan Carapetis and Fiona Stanley.
Engaging the community in COVID-19 rapid research
The research that is reducing the impact on families done by The Kids Research Institute Australia.
Research
Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19 - A scoping reviewThe primary objectives of this study were to assess the usefulness of C-reactive protein and procalcitonin in the diagnosis of bacterial co-infections in coronavirus disease 2019 (COVID-19) and if their incorporation in antimicrobial stewardship programs is safe and useful, stratified by severity of disease as level of care, intensive care unit (ICU) or non-ICU.